PHEOCHROMOCYTOMA/PARAGANGLIOMA
Clinical trials for PHEOCHROMOCYTOMA/PARAGANGLIOMA explained in plain language.
Never miss a new study
Get alerted when new PHEOCHROMOCYTOMA/PARAGANGLIOMA trials appear
Sign up with your email to follow new studies for PHEOCHROMOCYTOMA/PARAGANGLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare genetic tumor disorder: belzutifan trial launches
Disease control Recruiting nowThis study is for people with von Hippel-Lindau (VHL) syndrome, a rare genetic condition that causes tumors in various organs. Researchers want to see how well the drug belzutifan works at shrinking or controlling these tumors, and what side effects it may cause. About 100 partic…
Matched conditions: PHEOCHROMOCYTOMA/PARAGANGLIOMA
Phase: PHASE2 • Sponsor: José Claudio Casali da Rocha • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
New pill shows promise for rare cancers in phase 2 trial
Disease control Recruiting nowThis study tests a drug called belzutifan in people with certain rare or advanced cancers, including pheochromocytoma/paraganglioma, pancreatic neuroendocrine tumors, and tumors linked to von Hippel-Lindau disease. The goal is to see if the drug shrinks tumors or stops them from …
Matched conditions: PHEOCHROMOCYTOMA/PARAGANGLIOMA
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
Hunt for hidden cancer genes in families
Knowledge-focused Recruiting nowThis research study aims to discover new genes that may increase the risk of childhood cancer. Researchers will collect blood samples and health information from 1,500 people in families where cancer clusters. The goal is to build a registry and sample bank to help future diagnos…
Matched conditions: PHEOCHROMOCYTOMA/PARAGANGLIOMA
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated May 19, 2026 12:00 UTC